# Plasma Soluble Urokinase Plasminogen Activator Receptor and Behçet's Disease .

> **NCT04105439** · — · UNKNOWN · sponsor: **Assiut University** · enrollment: 90 (estimated)

## Conditions studied

- Behçet Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04105439
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-01
- **Primary completion:** 2021-11-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2021-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04105439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04105439, "Plasma Soluble Urokinase Plasminogen Activator Receptor and Behçet's Disease .". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT04105439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*